BCL2 and B-cell chronic lymphocytic leukemia: Although CLL cells activate transcriptional programs to counteract ApoE toxicity, they remain vulnerable to pharmacologically induced ferroptosis, indicating that induction of ferroptosis could be a promising strategy to overcome CLL's resistance to apoptotic cell death and Bcl-2 inhibitors [100].